Evotec SE is a drug discovery partnership company providing drug discovery solutions to pharmaceutical and biotechnology company, academic institutions as well as to foundations and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes and complications of diabetics, pain and inflammation, oncology and infectious diseases. Its business segments are EVT execute and EVT Innovate. The EVT execute provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programmes and assets, both internally or through academic collaborations.